Back to Search
SRIVANI KARRA, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1225126758IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
241535(NY)MD460060(PA)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
OTHER
Class of 1994
Research & Publications (12)
Microorganisms in bioaerosol emissions from wastewater treatment plants during summer at a Mediterranean site.
PMID 17275877·Water Res·2007
8-other
The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-beta-driven transcription in response to interferon-gamma.
PMID 18339625·J Biol Chem·2008
7-preclinical
Synthesis and evaluation of a gamma-lactam as a highly selective EP2 and EP4 receptor agonist.
PMID 18039575·Bioorg Med Chem Lett·2008
7-preclinical
Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists.
PMID 17931866·Bioorg Med Chem Lett·2007
4-observational
Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists.
PMID 17531488·Bioorg Med Chem Lett·2007
7-preclinical
Thioredoxin reductase plays a critical role in IFN retinoid-mediated tumor-growth control in vivo.
PMID 12374691·Clin Cancer Res·2002
4-observational
Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
PMID 12214272·Oncogene·2002
8-other
Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
PMID 11464290·Oncogene·2001
8-other
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination.
PMID 11439333·Oncogene·2001
8-other
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductase.
PMID 11331281·J Biol Chem·2001
7-preclinical
Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M.
PMID 14727873·AAPS PharmSciTech·2001
8-other
The interferon-beta and tamoxifen combination induces apoptosis using thioredoxin reductase.
PMID 10771088·Biochim Biophys Acta·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1255 S CEDAR CREST BLVD, SUITE 2100
ALLENTOWN, PA 18103 - Phone
- (610) 402-6555
Quick Facts
- NPI
- 1225126758
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 32
- Publications
- 12
Are you this provider?
Claim Your Profile